ASH 2009 meeting report - Top 10 clinically oriented abstracts in acute leukemia

Amber Fullmer, Jorge Cortes, Hagop Kantarjian, Elias Jabbour

Research output: Contribution to journalArticle

Abstract

The 2009 American Society of Hematology (ASH) annual meeting introduced novel strategies for the treatment of acute leukemia. Targeted inhibitors for both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) represent the future of these malignancies. Inclusion of targeted treatment to combination chemotherapy may translate into improved cure rates. The most clinically relevant abstracts, all of which are published in the November 2009, 114 issue of Blood, are summarized below and are identified here by their abstract numbers.

Original languageEnglish (US)
Pages (from-to)277-280
Number of pages4
JournalAmerican Journal of Hematology
Volume85
Issue number4
DOIs
StatePublished - Apr 1 2010
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'ASH 2009 meeting report - Top 10 clinically oriented abstracts in acute leukemia'. Together they form a unique fingerprint.

  • Cite this